Dec 29, 2017
Pharmaceutical Executive
Amid a widening net of health threats worldwide, alliances forged in research and response may be more critical than ever to stem the tide.
Dec 10, 2017
Pharmaceutical Executive
New action plan urges tighter alignment of public health policy with the development of targeted therapies.
Dec 01, 2017
The Chinese government's “Healthy China” plan presents an unprecedented opportunity for the US healthcare industry and its investors, writes Steven Shill.
Nov 21, 2017
By Pharmaceutical Executive Editors
UK commentators point to job losses and disruption to patients following news that the European Medicines Agency (EMA) will be relocated to Amsterdam.
Nov 15, 2017
Andrew Lane, EVP, Established Pharmaceuticals at Abbott, tells Pharm Exec how understanding emerging market dynamics can explain why branded generic medicines are important.
Nov 13, 2017
Pharmaceutical Executive
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.
Nov 07, 2017
While most pharma companies are in partial production using generators, few are operating at 100% capacity, writes Jill Wechsler.
Nov 07, 2017
A year after the Accelerated Access Review explored how to speed up adoption of innovation across the NHS in England, the UK Government has responded. Leela Barham reports.
Nov 06, 2017
Pharmaceutical Executive
Can health stakeholders be friends without being captives? Reflector reports.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
lorem ipsum